Associate Professor, Medicine, Brown University Program in Medicine

Infectious Disease

Dr. Michelle A. Lally, MD

Michelle Lally is an expert in the field of Infectious Disease. She attended University of Virginia School of Medicine. Michelle Lally is also published. She has 42 publications published. The lastest publication: "Legionella bozemanii pneumonia in three patients with AIDS.' Michelle Lally is registered with Medicare and accepts Medicare payments.

Publications

Clinician Attitudes Toward CDC Interim Pre-Exposure Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents.
Adolescent decision making about participation in a hypothetical HIV vaccine trial.
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.
Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1 Uninf...
Evaluation of an Intervention Among Adolescents to Reduce Preventive Misconception in HIV Vaccine Clinical Trials.
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.
Preventive misconception and adolescents' knowledge about HIV vaccine trials.
Correlates of willingness to participate in microbicide research among African Americans.
OPRM1 and Diagnosis-Related Posttraumatic Stress Disorder in Binge-Drinking Patients Living with HIV.
Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Keeping the Faith: African American Faith Leaders' Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection.
HIV testing and linkage to services for youth.
Web-based, mobile-device friendly, self-report survey system incorporating avatars and gaming console techniques.
Legionella bozemanii pneumonia in three patients with AIDS.
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
Where to begin human papillomavirus vaccination?
Willingness to receive an HIV vaccine among incarcerated persons.
Hepatitis B and C in the context of HIV disease: implications for incarcerated populations.
Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.
Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches.
HIV vaccine update: recent developments and current trials.
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.
Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience.
HIV testing in the setting of inpatient acute substance abuse treatment.
HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment.
Risk factors for syphilis among incarcerated women in Rhode Island.
Feasibility and acceptability of rapid HIV testing in jail.
Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines.
A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center.
A review of the case for hepatitis B vaccination of high-risk adults.
Routine, not risk-based, human immunodeficiency virus testing is the way to go.
Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment.
Routine HIV testing among inpatients.
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.
HPV vaccination practices among juvenile justice facilities in the United States.
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.
HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.
A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV.
HIV testing experiences among male and female inmates in Rhode Island.
HPV vaccination an opportune time for HIV testing.

Schools

University of Virginia Main Campus
Beth IsraelDeaconess Mc Harvard Med School

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

Beth Israel Deaconess Medical Center
University of Virginia School of Medicine

Hospital

Rhode Island Hospital

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Eleftherios Mylonakis, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Marisa Holubar, MD This Doctor is OpenDoctor Recommended.
	Dr. Davinderpal Singh, MD This Doctor is OpenDoctor Recommended.
	Dr. Bich-Thuy T. Sim, MD
	Dr. Rami A. Kantor, MD This Doctor is OpenDoctor Recommended.
	Dr. Gary R. Plotkin, MD This Doctor is OpenDoctor Recommended.
	Dr. Patricia A. Cristofaro, MD This Doctor is OpenDoctor Recommended.
	Dr. Gail Skowron, MD This Doctor is OpenDoctor Recommended.
	Dr. Anne De Groot, MD
	Dr. Jonathan Dworkin, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward J. Wing, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Erica J. Hardy, MD This Doctor is OpenDoctor Recommended.
	Dr. Charlene Flash, MD This Doctor is OpenDoctor Recommended.